In ovarian cancer, high levels of AT1R expression are linked to increased rates of tumor angiogenesis and a poor prognosis, and AT1R blockers have been shown to inhibit peritoneal spread of ovarian cancer in a mouse model (88). Here, AGTR1 is linked to ovarian carcinoma.